Stocksigma LogoStocksigma Logo

Alkem Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 45,520 (+13.8% YoY | +21.7% QoQ) ■ EBITDA: 10,252 (+11.3% YoY | +33.8% QoQ) ■ EBITDA Margin (%): 22.5 (-49 bps YoY | +204 bps QoQ) ■ PAT: 6,753

Alkem Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Alkem Laboratories Ltd · Outcome · 12 Nov 2026, 7:20 pm

Alkem Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 45,520 (+13.8% YoY | +21.7% QoQ) ■ EBITDA: 10,252 (+11.3% YoY | +33.8% QoQ) ■ EBITDA Margin (%): 22.5 (-49 bps YoY | +204 bps QoQ) ■ PAT: 6,753 (-11.7% YoY | +29.9% QoQ) ■ EPS (INR): 56.5 (-11.7% YoY | +29.9% QoQ) Alkem Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Pharmaceuticals ■ Revenue: 43,479 (+11.8% YoY | +19.0% QoQ) ■ EBIT: 10,519 (+26.3% YoY | +36.7% QoQ) ■ EBIT Margin (%): 24.2 (+278 bps YoY | +313 bps QoQ) Biotech ■ Revenue: 1,298 (-18.0% YoY | +8.3% QoQ) ■ EBIT: -1,141 (Profit to Loss YoY | -25.0% QoQ) ■ EBIT Margin (%): -87.9 (Profit to Loss YoY | -1179 bps QoQ) MedTech ■ Revenue: 1,331 (+4831.1% YoY | +1640.4% QoQ) ■ EBIT: -496 (-686.5% YoY | -305.1% QoQ) ■ EBIT Margin (%): -37.3 (+19643 bps YoY | +12285 bps QoQ)

Original exchange filing (PDF)

More announcements from Alkem Laboratories Ltd

All Alkem Laboratories Ltd announcements